Publications
- Expression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinoma2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- The authors' own experience with axitinib in treating metastatic renal cell carcinoma2018 | First Faculty of Medicine
- Docetaxel-Cabazitaxel-Enzalutamide Versus Docetaxel-Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer2017 | First Faculty of Medicine
- Klinická onkologie2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic cancer2023 | First Faculty of Medicine, Third Faculty of Medicine
- Strategies for the treatment of urothelial carcinoma of the bladder2023 | First Faculty of Medicine
- Strategies for the treatment of urothelial carcinoma2023 | First Faculty of Medicine
- Enzalutamide and abiraterone in the treatment of patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy2023 | First Faculty of Medicine
- PARP inhibitors in treating metastatic castration-resistant prostate cancer2023 | First Faculty of Medicine
- Triplet in the treatment of hormone-sensitive prostate cancer2023 | First Faculty of Medicine
Loading network view...